MedTrace Logo

Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals

NCT02007343 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3895

Last updated 2019-11-08

No results posted yet for this study

Summary

This study aims to assess how large an additional disease burden and what extra costs are generated by antibiotic resistance in patients suffering from infections caused by gram-negative bacteria, such as Escherichia coli and Pseudomonas aeruginosa, in hospitals in the Netherlands.

Conditions

  • Infection Resistant to Drugs
  • Gram-Negative Bacterial Infection

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Marc JM Bonten, MD PhD · UMC Utrecht, Utrecht, the Netherlands

  • Heidi SM Ammerlaan, MD PhD · Catharina Hospital, Eindhoven, the Netherlands

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-03-31
Completion
2016-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02007343 on ClinicalTrials.gov